Malignancy in a series of 70 patients with systemic lupus erythematosus.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000209:etiology*; D002294:Carcinoma, Squamous Cell / Q000209:etiology*; D002648:Child; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000209:etiology*; D012878:Skin Neoplasms / Q000209:etiology*; D002583:Uterine Cervical Neoplasms / Q000209:etiology*
D000305:Adrenal Cortex Hormones; D001379:Azathioprine